INS and metabolic dysfunction-associated steatotic liver disease: All parameters related to glucose metabolism, including fasting blood glucose (118.3 ± 32.0 mg/dL vs. 101.9 ± 25.2 mg/dL, p < 0.001), HbA1c (6.2 ± 0.8% vs. 5.7 ± 0.7%, p < 0.001), insulin (13.3 ± 17.0 μU/mg vs. 6.0 ± 5.1 μU/mg, p < 0.001), and HOMA-IR (4.0 ± 6.0 vs. 1.5 ± 1.3, p < 0.001), were significantly higher in the non-obese NAFLD group.